B
Bull
Bull · 25%DCGO
$1.06
Precio del escenario
$0.398
-0.016 (-4.15%)Al cierre
Loading chart…
- High
- 0.425
- Open
- 0.420
- VWAP
- 0.41
- Vol
- 653.09K
- Mkt Cap
- 326.03M
- Low
- 0.395
- Amount
- 265.05K
- EV/EBITDA, TTM
- -0.63
DocGo Inc. is a mobile healthcare services company that uses dispatch and communication technology to help provide mobile, in-person medical treatment directly to patients in the comfort of their homes, workplaces and other non-traditional locations and healthcare transportation in major metropolitan cities in the United States and the United Kingdom. The Company’s offerings also include mobile phlebotomy lab services, which is engaged in addressing critical gaps in diagnostic care for underserved populations. The Mobile Health Services include a variety of healthcare services performed at homes, offices and other locations and event services, such as on-site healthcare support at sporting events and concerts. The Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports.
AI analysis of DocGo Inc (DCGO)
sellDocGo Inc is not a good buy right now due to its significant financial losses and declining revenue. The current price is $0.3975, and the company reported a loss of $15.82 million in Q2 2026, which is a deterioration from a loss of $11.16 million in the same quarter last year. Furthermore, the stock has a low RSI of 30.719, indicating it is oversold, but the overall trend is negative with a year-to-date change of -55.24%.
Métricas de valoración
The current forward P/E ratio for DocGo Inc (DCGO) is 60.24, compared to its 5-year average forward P/E of 30.14.
Alphio AI Price Scenarios for DCGO
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Cronología de eventos
Noticias
9.508-19Yahoo FinanceDocGo Q2 2026 Earnings Analysis
8.508-18NewsfilterKey Highlights from DuckGo's Q2 Earnings Call
9.508-18NASDAQ.COMDocGo Reports Increased Losses in Q2
- 8.508-17Newsfilter
DocGo Announces Acquisition of Hicuity Health and Q2 Financial Results
- 9.508-14Newsfilter
DocGo Inc. to Report Q2 Earnings with Mixed Analyst Ratings
DCGO FAQ — answered by Alphio AI
DocGo Inc. is a mobile healthcare services company that uses dispatch and communication technology to help provide mobile, in-person medical treatment directly to patients in the comfort of their homes, workplaces and other non-traditional locations and healthcare transportation in major metropolitan cities in the United States and the United Kingdom. The Company’s offerings also include mobile phlebotomy lab services, which is engaged in addressing critical gaps in diagnostic care for underserved populations. The Mobile Health Services include a variety of healthcare services performed at homes, offices and other locations and event services, such as on-site healthcare support at sporting events and concerts. The Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).
DocGo Inc is not a good buy right now due to its significant financial losses and declining revenue. The current price is $0.3975, and the company reported a loss of $15.82 million in Q2 2026, which is a deterioration from a loss of $11.16 million in the same quarter last year. Furthermore, the stock has a low RSI of 30.719, indicating it is oversold, but the overall trend is negative with a year-to-date change of -55.24%.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.